1. Asthma
Definition
Chronic inflammatory airway disease with:
-
Reversible airflow obstruction
-
Airway hyperresponsiveness
-
Often linked to atopy and environmental triggers
Mnemonic: AIR
Airway inflammation
Intermittent symptoms
Reversible obstruction
🧬 Pathophysiology
-
Trigger (allergen, infection, exercise, cold air) → immune activation
-
Mast cells → histamine, leukotrienes → bronchial smooth muscle contraction
-
Eosinophils (IL-5 driven) → airway inflammation
-
Mucosal oedema + mucus hypersecretion → narrowed airways
🛡️ Risk Factors (Mnemonic: ASTHMIC)
Atopy (eczema, hay fever)
Smoking (active/passive)
Triggers (cold, dust, pets, pollen)
Household irritants (mould, damp)
Medications (NSAIDs, β-blockers)
Infections (esp. viral in childhood)
Childhood/family history

🤒 Symptoms (Mnemonic: WHACK)
Wheeze (expiratory, polyphonic)
Heavy chest (tightness)
At night/early morning (worse)
Cough (often dry, variable)
Keen trigger sensitivity (exercise, pets, dust, cold)
Symptoms are episodic and worse on exertion or allergen exposure.
🚩 Red Flags / Severe Features
Silent chest, exhaustion, confusion → impending respiratory failure
Life-threatening asthma: SpO₂ <92%, PEF <33%, silent chest, cyanosis, arrhythmia, hypotension
Near-fatal asthma: Raised PaCO₂ or need for mechanical ventilation
🔬 Investigations
Test | Use | Exam Notes |
---|---|---|
Spirometry with reversibility | Obstructive pattern (FEV₁/FVC <70%) + ≥12% & ≥200 ml ↑ FEV₁ post-bronchodilator | Diagnostic gold standard |
Peak flow monitoring | Variability >20% = diagnostic | Diurnal variation: morning dipping worse |
FeNO | Raised in eosinophilic inflammation | NICE recommends in uncertain cases |
Allergy testing | RAST/skin prick if atopy suspected | Not first-line |
Bloods | May show eosinophilia | Rule out differentials |
CXR | If atypical / to exclude pneumonia | Often normal in asthma |
🩻 CXR Findings (Mnemonic: THUMP)
Thickened bronchial walls
Hyperinflated lungs (flattened diaphragms)
Unusual findings suggest another cause
Mediastinal shift (if tension pneumothorax)
Pneumothorax / pneumomediastinum
📊 Severity of Acute Asthma (BTS/NICE)
Classification | Features |
---|---|
Moderate | PEFR 50–75%, speaks in full sentences |
Severe | PEFR 33–50%, RR >25, HR >110, can’t finish sentences |
Life-threatening | PEFR <33%, SpO₂ <92%, silent chest, cyanosis, confusion, hypotension |
Stepwise Management (NICE 2022 Update)
Key Shift: MART Preferred
MART (Maintenance and Reliever Therapy) is now first-line for many adults and young people using:
Low-dose ICS-formoterol as both daily preventer and reliever
(e.g. Fostair, Symbicort)
Mnemonic: SMART PLAN
SABA no longer routinely used if on MART
MART preferred for many (ICS-formoterol)
Add-on therapy if uncontrolled: LTRA, ↑ICS
Review inhaler technique and adherence
Tailor plan to patient age and symptom pattern
Personalised asthma action plan
Low-dose ICS if not suitable for MART
Adult vs child algorithms differ
NICE stepwise diagram guides escalation
📋 Stepwise Treatment Ladder
Step | Treatment | Notes |
---|---|---|
1 | MART (low-dose ICS–formoterol) daily + PRN | Preferred adult first-line |
2 | Increase ICS dose or add LTRA (montelukast) | Watch behavioural SE |
3 | Switch to alternative inhaler regimen or ↑ICS | Specialist review if uncontrolled |
Children <5 | SABA trial → daily ICS if frequent | MART not licensed |
Offer a structured review to people with asthma at least annually.
More frequent reviews may be needed after treatment changes or exacerbations.
🚨 Acute Asthma Management (Mnemonic: O SHIT ME)
Oxygen (aim SpO₂ 94–98%)
Salbutamol (neb or inhaler)
Hydrocortisone IV / Prednisolone PO
Ipratropium (neb, esp. in severe)
Theophylline (specialist input only)
Magnesium sulfate IV (for life-threatening cases)
Escalate care → HDU/ICU if deteriorating
Monitoring & Review
Annual asthma review
Personalised Asthma Action Plan (PAAP)
Check inhaler technique and trigger control
Consider stepping down therapy if controlled for ≥3 months
⚠️ Complications
Mnemonic: RAMP
Respiratory failure
Air leaks – pneumothorax or pneumomediastinum
Mucus plugging
Persistent hypoxaemia
❓ Differential Diagnoses (Mnemonic: VACUUM)
Vocal cord dysfunction
Anaphylaxis
COPD
Upper airway obstruction
Undiagnosed cardiac disease (HF)
MSK chest pain
🔎 Key PARA Exam Traps
Reversibility (≥12% & ≥200 ml FEV₁) = asthma; irreversible = COPD
Life-threatening asthma signs: silent chest, PEF <33%, SpO₂ <92%
Near-fatal = raised PaCO₂ or ventilation
Always give O₂ with neb salbutamol (not air)
ICS started early (≥3 SABA uses/week)
Montelukast → behavioural SEs
ICS inhalers → rinse mouth to prevent oral candidiasis
Only adults use MART
Cardioselective β-blockers (bisoprolol) may be safe but exam trap
📅 Last updated in line with:
NICE NG80 (Asthma: diagnosis, monitoring and chronic management) – Nov 2022
BTS/SIGN Asthma Guideline – 2019
PARA-aligned, reviewed July 2025
PASSMAP ensures all content is NICE-aligned and exam-optimised for the Physician Associate Regulation Assessment (PARA).